DiaSorin S.p.A.
DSRLFOTCHealthcare● Active
$84.10
+$0.00(+0.00%)
Market Cap$4.5B
P/E Ratio—
52W High$112.3
52W Low$66.5
DiaSorin S.p.A. (DSRLF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · DSRLF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.19B | $1.19B | $1.15B | $1.36B | $1.24B |
| Cost of Revenue | $0.42B | $0.40B | $0.41B | $0.46B | $0.41B |
| Gross Profit | $0.77B | $0.78B | $0.74B | $0.90B | $0.82B |
| Gross Margin %(computed) | 64.69% | 65.94% | 64.55% | 66.17% | 66.64% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.09B | $0.09B | $0.10B | $0.07B |
| G&A Expenses | $0.00B | $0.12B | $0.13B | $0.11B | $0.09B |
| Total Operating Expenses | $0.54B | $0.52B | $0.52B | $0.55B | $0.41B |
| Operating Income | $0.23B | $0.26B | $0.22B | $0.35B | $0.42B |
| Operating Margin %(computed) | 19.08% | 21.79% | 18.83% | 25.81% | 33.89% |
| Interest Income | $0.00B | $0.01B | $0.02B | $0.01B | $0.00B |
| Interest Expense | $0.02B | $0.03B | $0.03B | $0.03B | $0.02B |
| Income Before Tax | $0.21B | $0.24B | $0.20B | $0.33B | $0.40B |
| Income Tax Expense | $0.06B | $0.06B | $0.04B | $0.09B | $0.09B |
| Net Income | $0.15B | $0.19B | $0.16B | $0.24B | $0.31B |
| Net Margin %(computed) | 12.55% | 15.87% | 13.92% | 17.70% | 25.13% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $2.68 | $3.37 | $2.87 | $4.17 | $5.44 |
| Wtd Avg Shares | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B |
| EBITDA | $0.23B | $0.40B | $0.33B | $0.48B | $0.50B |
| EBITDA Margin %(computed) | 19.08% | 33.66% | 29.04% | 35.24% | 40.77% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · EUR · B
Explore more DiaSorin S.p.A. data
About DiaSorin S.p.A. (DSRLF) Income Statement
DiaSorin S.p.A. (DSRLF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, DSRLF reported revenue of $1.19B, gross profit of $0.77B (gross margin 64.69%), and net income of $0.15B — a net profit margin of 12.55%.
Frequently asked questions
DSRLF · 4 questionsDiaSorin S.p.A. (DSRLF) reported revenue of $1.19B for 2025, up 0.8% year-over-year.
DSRLF revenueDSRLF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09